AMBOSS, a leading provider of clinical resources for medical professionals, has announced its acquisition of NEJM Knowledge+ from NEJM Group, heralding a new era in medical education and clinical practice. This strategic move cements AMBOSS's position as a powerhouse in evidence-based medicine and underscores its commitment to delivering cutting-edge learning tools for healthcare professionals worldwide.
NEJM Knowledge+ is a renowned learning and assessment platform developed by NEJM Group, the publishers of the prestigious New England Journal of Medicine. Trusted by over 500 residency programs in Internal Medicine, Family Medicine, and Pediatrics, NEJM Knowledge+ has set the standard for adaptive-learning board preparation question banks since its inception in 2014.
The integration of NEJM Knowledge+ with AMBOSS's robust clinical decision support tool represents a significant leap forward in medical education. This merger creates an unparalleled resource for healthcare professionals, offering a comprehensive platform that seamlessly integrates board exam preparation with real-world clinical practice.
AMBOSS has long been recognized for its user-friendly interface and extensive medical library, making it a preferred choice among medical students and residents alike. With approximately 25% of first-year US residents already relying on AMBOSS for clinical decision support, the acquisition of NEJM Knowledge+ further solidifies AMBOSS's position as a leader in medical education.
The acquisition underscores AMBOSS and NEJM Group's shared commitment to advancing medical education and enhancing patient outcomes. As healthcare professionals and students increasingly seek personalized learning experiences and point-of-care clinical knowledge, the combined platform aims to meet their evolving needs at every stage of their careers.
Click here to read the original press release.
